Literature DB >> 33686176

Dynamic roles of inflammasomes in inflammatory tumor microenvironment.

Jeong-Hoon Jang1, Do-Hee Kim2, Young-Joon Surh3,4,5.   

Abstract

The inflammatory tumor microenvironment has been known to be closely connected to all stages of cancer development, including initiation, promotion, and progression. Systemic inflammation in the tumor microenvironment is increasingly being recognized as an important prognostic marker in cancer patients. Inflammasomes are master regulators in the first line of host defense for the initiation of innate immune responses. Inflammasomes sense pathogen-associated molecular patterns and damage-associated molecular patterns, following recruitment of immune cells into infection sites. Therefore, dysregulated expression/activation of inflammasomes is implicated in pathogenesis of diverse inflammatory disorders. Recent studies have demonstrated that inflammasomes play a vital role in regulating the development and progression of cancer. This review focuses on fate-determining roles of the inflammasomes and the principal downstream effector cytokine, IL-1β, in the tumor microenvironment.

Entities:  

Year:  2021        PMID: 33686176     DOI: 10.1038/s41698-021-00154-7

Source DB:  PubMed          Journal:  NPJ Precis Oncol        ISSN: 2397-768X


  131 in total

Review 1.  The inflammatory tumor microenvironment and its impact on cancer development.

Authors:  Karin E de Visser; Lisa M Coussens
Journal:  Contrib Microbiol       Date:  2006

Review 2.  The inflammasomes.

Authors:  Kate Schroder; Jurg Tschopp
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

Review 3.  Macrophage diversity enhances tumor progression and metastasis.

Authors:  Bin-Zhi Qian; Jeffrey W Pollard
Journal:  Cell       Date:  2010-04-02       Impact factor: 41.582

Review 4.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

5.  The tumor microenvironment at a glance.

Authors:  Frances R Balkwill; Melania Capasso; Thorsten Hagemann
Journal:  J Cell Sci       Date:  2012-12-01       Impact factor: 5.285

Review 6.  Inflammasomes in carcinogenesis and anticancer immune responses.

Authors:  Laurence Zitvogel; Oliver Kepp; Lorenzo Galluzzi; Guido Kroemer
Journal:  Nat Immunol       Date:  2012-03-18       Impact factor: 25.606

Review 7.  Inflammasomes: mechanism of action, role in disease, and therapeutics.

Authors:  Haitao Guo; Justin B Callaway; Jenny P-Y Ting
Journal:  Nat Med       Date:  2015-06-29       Impact factor: 53.440

Review 8.  The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages.

Authors:  Paola Allavena; Antonio Sica; Graziella Solinas; Chiara Porta; Alberto Mantovani
Journal:  Crit Rev Oncol Hematol       Date:  2007-10-29       Impact factor: 6.312

Review 9.  Immunological and inflammatory functions of the interleukin-1 family.

Authors:  Charles A Dinarello
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

Review 10.  Inflammasomes in cancer: a double-edged sword.

Authors:  Ryan Kolb; Guang-Hui Liu; Ann M Janowski; Fayyaz S Sutterwala; Weizhou Zhang
Journal:  Protein Cell       Date:  2014-01-29       Impact factor: 14.870

View more
  11 in total

1.  Chemogenetic modulation of sensory neurons reveals their regulating role in melanoma progression.

Authors:  Pedro A C Costa; Walison N Silva; Pedro H D M Prazeres; Caroline C Picoli; Gabriela D A Guardia; Alinne C Costa; Mariana A Oliveira; Pedro P G Guimarães; Ricardo Gonçalves; Mauro C X Pinto; Jaime H Amorim; Vasco A C Azevedo; Rodrigo R Resende; Remo C Russo; Thiago M Cunha; Pedro A F Galante; Akiva Mintz; Alexander Birbrair
Journal:  Acta Neuropathol Commun       Date:  2021-11-16       Impact factor: 7.801

2.  Prognostic Value of a Serum Panel of Inflammatory Factors in Non-Metastatic Nasopharyngeal Carcinoma Patients Undergoing Radical Radiotherapy with Adjuvant Chemotherapy.

Authors:  Ting Liang; Ding Xiao; Shanshan Lu; Xu Ye; Zhiqiang Xiao
Journal:  Cancer Manag Res       Date:  2022-09-16       Impact factor: 3.602

Review 3.  Biological Rationale for Peripheral Blood Cell-Derived Inflammatory Indices and Related Prognostic Scores in Patients with Advanced Non-Small-Cell Lung Cancer.

Authors:  Giuseppe Luigi Banna; Alex Friedlaender; Marco Tagliamento; Veronica Mollica; Alessio Cortellini; Sara Elena Rebuzzi; Arsela Prelaj; Abdul Rafeh Naqash; Edouard Auclin; Lucia Garetto; Laura Mezquita; Alfredo Addeo
Journal:  Curr Oncol Rep       Date:  2022-10-18       Impact factor: 5.945

Review 4.  Inflammation: A New Look at an Old Problem.

Authors:  Evgenii Gusev; Yulia Zhuravleva
Journal:  Int J Mol Sci       Date:  2022-04-21       Impact factor: 6.208

Review 5.  Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Molecules       Date:  2021-10-15       Impact factor: 4.411

6.  D-Dimer Is a Predictive Factor of Cancer Therapeutics-Related Cardiac Dysfunction in Patients Treated With Cardiotoxic Chemotherapy.

Authors:  Masayoshi Oikawa; Daiki Yaegashi; Tetsuro Yokokawa; Tomofumi Misaka; Takamasa Sato; Takashi Kaneshiro; Atsushi Kobayashi; Akiomi Yoshihisa; Kazuhiko Nakazato; Takafumi Ishida; Yasuchika Takeishi
Journal:  Front Cardiovasc Med       Date:  2022-01-21

Review 7.  Clinical Applications and Anticancer Effects of Antimicrobial Peptides: From Bench to Bedside.

Authors:  Ameneh Jafari; Amirhesam Babajani; Ramin Sarrami Forooshani; Mohsen Yazdani; Mostafa Rezaei-Tavirani
Journal:  Front Oncol       Date:  2022-02-23       Impact factor: 6.244

8.  Inflammation suppresses DLG2 expression decreasing inflammasome formation.

Authors:  Simon Keane; Matthew Herring; Peter Rolny; Yvonne Wettergren; Katarina Ejeskär
Journal:  J Cancer Res Clin Oncol       Date:  2022-05-02       Impact factor: 4.322

9.  Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways.

Authors:  Ghmkin Hassan; Toshiaki Ohara; Said M Afify; Kazuki Kumon; Maram H Zahra; Xiaoying Fu; Mohamad Al Kadi; Akimasa Seno; David S Salomon; Masaharu Seno
Journal:  J Exp Clin Cancer Res       Date:  2022-01-21

Review 10.  The Interplay between Tumour Microenvironment Components in Malignant Melanoma.

Authors:  Cornelia Amalinei; Adriana Grigoraș; Ludmila Lozneanu; Irina-Draga Căruntu; Simona-Eliza Giușcă; Raluca Anca Balan
Journal:  Medicina (Kaunas)       Date:  2022-03-02       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.